News

A blood test that may detect cancer has received attention recently. But, unlike other blood tests being studied to screen for cancer, it wasn’t designed for that purpose. This test is a prenatal blood test that analyzes… read more

More than a century after Aldred Scott Warthin, M.D., Ph.D., a pathologist at the University of Michigan, first suspected heredity lay behind one family’s numerous cancers, scientists have begun testing two experimental… read more

Despite intense research, liver cancer prevention remains a challenge. Current efforts are directed at underlying conditions that can significantly raise an individual’s risk, including hepatitis C infection, for which… read more

Eleven DCP/PREVENT presentations were delivered at the 2023 AACR Annual meeting, including: five poster sessions, one informational session with four staff from the NCI Division of Cancer Prevention, and two staff sessions… read more

Early-onset colorectal cancer is considered relatively rare, but both incidence and mortality rates are increasing in people under age 50. NCI recently issued a special research request for grant applications in areas such… read more

The executive summary of the second PARTNRS (Primary Care Alliance in Research Trials Involving NCORP Sites) Workshop is now available. PARTNRS is a strategic initiative to encourage and forge partnerships between oncologists and primary care providers to promote patient accrual into cancer… read more

Researchers have recruited the first vaccine candidates to one of two new prevention trials that seek to immunize high-risk individuals against cancers associated with Lynch syndrome, the most common cause of hereditary colorectal cancer. Individuals who inherit the condition have an estimated… read more

We present ULACNet-302 Estudio Oportunidad: An opportunity to improve the health of women living with HIV, Recruitment strategies for the ULACNet 201 study in Puerto Rico, and Use of a mobile application as a strategy to… read more

Chemopreventive Agent Development Research Group, Division of Cancer Prevention The National Cancer Institute (NCI), Division of Cancer Prevention (DCP), is seeking a Program Director to manage the formulation, production and distribution of small molecule and biologic agents for preclinical and… read more

The National Cancer Institute’s (NCI’s) Board of Scientific Advisors (BSA) recently approved two new concept proposals aimed at expanding potential prevention interventions.

  A JNCI monograph on Engaging Older Adults in Cancer Clinical Trials Conducted in the National Cancer Institute Clinical Trials Network is available now. The articles, developed through working groups formed for an NCI workshop held in April 2021 to address… read more

Staff Highlight, DMACC Updates (Data Management and Reporting Unit, CP-CTNET DMACC Public Website and Portal Gateway Update, Clinical Trials Auditing Unit, Administrative and Coordinating Unit), In Memoriam, and Research Funding Opportunities

This month’s Research Highlights focuses on provider and patient beliefs about mammogram screening frequency, and separately, provider barriers to engaging in shared decision-making with high-risk patients about the use of chemoprevention to reduce breast cancer risk. Both studies discuss the value… read more

The National Cancer Institute Division of Cancer Prevention has released three Funding Opportunity Announcements to accept applications to create the Cancer Screening Research Network (CSRN).  The CSRN will conduct rigorous, multi-center cancer screening trials… read more

Cervical cancer can be prevented by HPV vaccination and by screening for and treating precancerous lesions. Yet, millions of women globally remain at high-risk for developing cervical cancer. This is especially true for… read more

Cancer Biomarkers Research Group, Division of Cancer Prevention The National Cancer Institute (NCI) is seeking a Program Director to lead an innovative portfolio of research focused on biomarkers for cancer early detection and risk assessment within the Division of Cancer Prevention (DCP).… read more

Office of the Director, Division of Cancer Prevention The National Cancer Institute (NCI) is seeking a Program Director to lead an innovative portfolio of research focused on symptom management, palliative care, and quality of life research within the Division of Cancer Prevention (DCP).… read more

This issue of Research Highlights focuses on how cells progress to become breast cancer, and separately, how breast cancer may spread. Understanding these transitional moments can help researchers keep invasive cancer from forming, and help us keep invasive cancer from spreading. One study is about… read more

Featured Article: CP-CTNet Cross Network Study: Lynch Syndrome.  Inherited susceptibility to cancer involves defects in genes that normally function to suppress the formation of tumors. One such syndrome was recognized by Henry Lynch several decades ago based on clinical criteria, but is now known… read more

More than half of cancer survivors who were treated with chemotherapy for the four most common types of cancer experienced clinically significant hearing loss and tinnitus after treatment, according to new research. Christine Miaskowski, RN, Ph.D. The… read more

As we embark on year 4 of ULACNet, this issue highlights successes & opportunities, considers how we respond to the community voice in study recruitment, discusses community participation in ULACNet-201 trial recruitment… read more

Recruitment has begun for a clinical study that investigators hope will move “liquid biopsy” technology closer to its still-distant goal: a single blood test for the early detection of cancer. Collectively known as multi-cancer early detection (MCED) assays or sometimes multi-cancer detection… read more

Research Highlights are a new type of blog for Cancer Prevention Science, where recent publications are highlighted rather than a traditional news story. This month’s blog post highlights how a cruciferous vegetable extract reduces toxins from tobacco and reports the effects of Polyphenon E in… read more

In 2012, Patricia Ganz, M.D., saw a 39-year-old cancer survivor for a consultation who had a long-term history of anxiety during medical visits. Patricia Ganz, M.D. The woman had been diagnosed with Hodgkin lymphoma when she was 23 years old. Though her… read more

Welcome to the CP-CTNet Newsletter where we share programmatic and research updates for the Cancer Prevention Clinical Trials Network (CP-CTNet).